CANNAVO, ALESSANDRO
 Distribuzione geografica
Continente #
AS - Asia 2.588
EU - Europa 2.081
NA - Nord America 1.703
SA - Sud America 357
AF - Africa 65
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 6.799
Nazione #
US - Stati Uniti d'America 1.631
SG - Singapore 1.359
RU - Federazione Russa 1.012
CN - Cina 611
IT - Italia 467
BR - Brasile 293
HK - Hong Kong 216
VN - Vietnam 157
DE - Germania 120
IN - India 99
NL - Olanda 92
GB - Regno Unito 90
FI - Finlandia 68
UA - Ucraina 58
IE - Irlanda 43
FR - Francia 39
CA - Canada 34
KR - Corea 32
MX - Messico 29
AR - Argentina 27
BD - Bangladesh 27
CI - Costa d'Avorio 25
SE - Svezia 22
PL - Polonia 15
ZA - Sudafrica 14
EC - Ecuador 12
JP - Giappone 12
CO - Colombia 11
ES - Italia 11
IQ - Iraq 11
IR - Iran 11
ID - Indonesia 10
TR - Turchia 9
AT - Austria 8
CL - Cile 8
CZ - Repubblica Ceca 8
LT - Lituania 7
AE - Emirati Arabi Uniti 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
BE - Belgio 4
EG - Egitto 4
PK - Pakistan 4
KE - Kenya 3
MA - Marocco 3
TN - Tunisia 3
AU - Australia 2
BA - Bosnia-Erzegovina 2
BS - Bahamas 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
IL - Israele 2
KG - Kirghizistan 2
LB - Libano 2
LU - Lussemburgo 2
MR - Mauritania 2
NG - Nigeria 2
PA - Panama 2
PT - Portogallo 2
PY - Paraguay 2
RS - Serbia 2
SN - Senegal 2
VE - Venezuela 2
XK - ???statistics.table.value.countryCode.XK??? 2
AD - Andorra 1
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
DM - Dominica 1
EU - Europa 1
GP - Guadalupe 1
GR - Grecia 1
HU - Ungheria 1
JO - Giordania 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
MY - Malesia 1
MZ - Mozambico 1
PE - Perù 1
SO - Somalia 1
TH - Thailandia 1
Totale 6.799
Città #
Singapore 637
Moscow 222
Hong Kong 214
Ashburn 207
Hefei 196
Chandler 181
Beijing 150
Naples 138
Amsterdam 88
Santa Clara 85
Millbury 76
Los Angeles 68
Napoli 65
Ho Chi Minh City 59
Dallas 45
Nanjing 41
Munich 36
São Paulo 34
Des Moines 33
Buffalo 32
Seoul 32
Hanoi 31
Lawrence 30
New York 30
Redondo Beach 27
Princeton 26
Boston 24
Frankfurt am Main 24
Turku 21
Nuremberg 19
The Dalles 19
Mexico City 18
Chicago 16
Ottawa 16
Pune 16
Kochi 15
Shenyang 15
Helsinki 14
Seattle 14
Warsaw 14
Milan 13
Minneapolis 12
Rio de Janeiro 12
Stockholm 12
Denver 11
Menlo Park 11
Tokyo 11
Wilmington 11
Formia 10
Phoenix 10
Belo Horizonte 9
Changsha 9
Lappeenranta 9
London 9
Dong Ket 8
Montreal 8
Roseville 8
Tehran 8
Vienna 8
Haiphong 7
Hebei 7
Orem 7
Brooklyn 6
Curitiba 6
Florence 6
Guangzhou 6
Houston 6
Manchester 6
Nanchang 6
Parma 6
Poplar 6
Rochdale 6
Afragola 5
Atlanta 5
Chennai 5
Dhaka 5
Dublin 5
Giugliano In Campania 5
Jakarta 5
Ninh Bình 5
Nola 5
Rome 5
Tashkent 5
Baku 4
Bengaluru 4
Brussels 4
Casavatore 4
Caserta 4
Da Nang 4
Gragnano 4
Jiaxing 4
Johannesburg 4
Miami 4
Nha Trang 4
Norwalk 4
Recife 4
Roubaix 4
Santiago 4
Shanghai 4
Washington 4
Totale 3.421
Nome #
Aging is associated with cardiac autonomic nerve fiber depletion and reduced cardiac and circulating BDNF levels 224
β-adrenergic receptors and G protein-coupled receptor kinase-2 in Alzheimer's disease: a new paradigm for prognosis and therapy? 139
Increased epicardial adipose tissue volume correlates with cardiac sympathetic denervation in patients with heart failure 135
Aldosterone Jeopardizes Myocardial Insulin and β-Adrenergic Receptor Signaling via G Protein-Coupled Receptor Kinase 2 130
Changes of plasma norepinephrine and serum N-terminal pro-brain natriuretic peptide after exercise training predict survival in patients with heart failure 128
Impact of diabetes mellitus on lymphocyte GRK2 protein levels in patients with heart failure 128
Why Do We Not Assess Sympathetic Nervous System Activity in Heart Failure Management: Might GRK2 Serve as a New Biomarker? 126
Age-related and heart failure-related beta-adrenergic receptor dysfunction: New therapeutic strategies for the treatment of cardiovascular diseases 124
β3AR-Dependent BDNF (Brain-Derived Neurotrophic Factor) Generation Limits Chronic Postischemic Heart Failure 123
Prognostic Value of Lymphocyte G Protein-Coupled Receptor Kinase-2 Protein Levels in Patients With Heart Failure 122
Age and sex mediated effects of estrogen and Β3-adrenergic receptor on cardiovascular pathophysiology 119
B1-Adrenergic Receptor and Sphingosine-1-Phosphate Receptor 1 (S1PR1) Reciprocal Downregulation Influences Cardiac Hypertrophic Response and Progression to Heart Failure: Protective Role of S1PR1 Cardiac Gene Therapy 118
Reduction of lymphocyte G protein-coupled receptor kinase-2 (GRK2) after exercise training predicts survival in patients with heart failure. 116
Aldosterone and Mineralocorticoid Receptor System in Cardiovascular Physiology and Pathophysiology 114
Impact of aging on cardiac sympathetic innervation measured by (123)I-mIBG imaging in patients with systolic heart failure 113
Infective Endocarditis: A Focus on Oral Microbiota 113
Prothymosin alpha protects cardiomyocytes against ischemia-induced apoptosis via preservation of Akt activation. 112
Negative impact of β-arrestin-1 on post-myocardial infarction heart failure via cardiac and adrenal-dependent neurohormonal mechanisms 112
βARKct gene-therapy improves β2-adrenergic receptor-dependent neoangiogenesis following hindlimb ischemia 109
Serum Galectin-3 and Aldosterone: potential biomarkers of cardiac complications in patients with COVID-19 108
Potential Bidirectional Relationship Between Periodontitis and Alzheimer's Disease. 106
Diabetes is Associated With Higher Lymphocyte G-Protein Coupled Receptor Kinase-2 (grk2) Protein Levels in Patients With Left Ventricle Dysfunction Independently From Heart Failure Status 101
Molecular modulation of post-ischemic cardiac remodeling by hindlimb ischemia 99
Molecular aspects of the cardioprotective effect of exercise in the elderly 98
Predisposing factors to heart failure in diabetic nephropathy: a look at the sympathetic nervous system hyperactivity 98
Induction of mitogen activated protein kinases in response to pressure overload: a novel possible biomarker for uncontrolled human hypertension. 97
Aldosterone and Myocardial Pathology 97
Genetic Catalytic Inactivation of GRK5 Impairs Cardiac Function in Mice Via Dysregulated P53 Levels 97
Myocardial pathology induced by aldosterone is dependent on non-canonical activities of G protein-coupled receptor kinases 96
Blockade of ??-adrenoceptors restores the GRK2-mediated adrenal ??(2) -adrenoceptor-catecholamine production axis in heart failure 95
Correction to :β adrenergic receptor kinase C-terminal peptide gene-therapy improves ß2-adrenergic receptor-dependent neoangiogenesis after hindlimb ischemia (Journal of Pharmacology and Experimental Therapeutics (2016) 356:2 (503–513) DOI: 10.1124/jpet.115.228411) 94
Protective role of Prothymosin alpha against cardiac ischemic injury . 93
GRK2 blockade with betaARKct is essential for cardiac beta2-adrenergic receptor signaling towards increased contractility. 92
Risk of acute myocardial infarction after transurethral resection of prostate in elderly 90
Sphingosine kinases and sphingosine 1-phosphate receptors: Signaling and actions in the cardiovascular system 88
Atrial fibrillation in the elderly: a risk factor beyond stroke 88
PORPHYROMONAS GINGIVALIS VIRULENCE FACTORS INDUCE TOXIC EFFECTS IN SH-SY5Y NEUROBLASTOMA CELLS: GRK5 MODULATION AS A PROTECTIVE STRATEGY 87
Serum endocan (ESM-1) as diagnostic and prognostic biomarker in Multisystem inflammatory syndrome in children (MIS-C) 87
Gene therapy for heart disease: Molecular targets, vectors and modes of delivery to myocardium 86
Burning Redoxstats in the Brainstem Lack of Nrf2 and the Rise of Hypertension 86
GRK2 as negative modulator of NO bioavailability: Implications for cardiovascular disease 85
Vascular Endothelial Growth Factor Blockade Prevents the Beneficial Effects of ??-Blocker Therapy on Cardiac Function, Angiogenesis and Remodeling in Heart Failure. 83
EGFR Trans-activation by Urotensin II Receptor is Mediated by Beta-arrestin Recruitment and Confers Cardioprotection in Pressure Overload-induced Cardiac Hypertrophy. 83
Novel missense mutations and unexpected multiple changes of RYR1 gene in 75 malignant hyperthermia families 82
US11235029B2-METHODS FOR TREATING HEART FAILURE WITH A TRKB AGONIST 81
Genetic deletion of uncoupling protein 3 exaggerates apoptotic cell death in the ischemic heart leading to heart failure 81
Galectins may serve as biomarkers in COVID-19: a comprehensive systematic review and meta-analysis 79
Structure-Based Design of Highly Selective and Potent G Protein-Coupled Receptor Kinase 2 Inhibitors Based on Paroxetine 78
Circulating brain-derived neurotrophic factor levels and heart failure: A systematic review and meta-analysis 75
Triglyceride-glucose index and heart failure: a systematic review and meta-analysis 74
Healthy aging: when periodontal health matters 74
Targeting β3-adrenergic receptors in the heart: Selective agonism and β-blockade 73
GRK2 Regulates α2-Adrenergic Receptor-Dependent Catecholamine Release in Human Adrenal Chromaffin Cells 72
Is the Hitman in Cardiac Death Hidden in the Sympathetic Nervous System Remodeling? 69
RESVERATROL SUPPLEMENTATION AS A NON-SURGICAL TREATMENT IN PERIODONTITIS AND RELATED SYSTEMIC CONDITIONS 68
Relationship between COVID-19 Mortality, Hospital Beds, and Primary Care by Italian Regions: A Lesson for the Future 63
Triglyceride-glucose index and obstructive sleep apnea: a systematic review and meta-analysis 60
Equol and Resveratrol Improve Bone Turnover Biomarkers in Postmenopausal Women: A Clinical Trial 57
Alteration of myocardial GRK2 produces a global metabolic phenotype 55
The importance of assessing the triglyceride-glucose index (TyG) in patients with depression: A systematic review 54
Induction of mitogen-activated protein kinases is proportional to the amount of pressure overload. 54
Periodontal Disease: A Risk Factor for Diabetes and Cardiovascular Disease 53
Editorial: Molecular Mechanisms Involved in Heart Failure, Parkinson?s, and Alzheimer?s Diseases 52
Endocan as a marker of endothelial dysfunction in hypertension: a systematic review and meta-analysis 51
Are Skeletal Muscle Changes during Prolonged Space Flights Similar to Those Experienced by Frail and Sarcopenic Older Adults? 49
Anti-Porphyromonas gingivalis antibody levels in patients with stroke and atrial fibrillation: a systematic review and meta-analysis 48
Assessing the association between triglyceride-glucose index and atrial fibrillation: a systematic review and meta-analysis 47
Molecular Mechanisms Underlying Chronic and Degenerative Diseases 47
Sex Differences in Cardiovascular Diseases: A Matter of Estrogens, Ceramides, and Sphingosine 1-Phosphate 47
Structural determinants influencing the potency and selectivity of indazole-paroxetine hybrid G protein-coupled receptor kinase 2 inhibitors 46
Eating Away at Heart Failure 46
Exploring the Association Between Cognitive Decline and Triglyceride-Glucose Index: A Systematic Review and Meta-Analysis. 45
Differential role of g protein-coupled receptor Kinase 5 in physiological versus pathological cardiac hypertrophy 45
Crystal structure of G protein-coupled receptor kinase 5 in complex with a rationally designed inhibitor 44
Targeting cardiac β-adrenergic signaling via GRK2 inhibition for heart failure therapy 43
Structure-Based Design, Synthesis, and Biological Evaluation of Highly Selective and Potent G Protein-Coupled Receptor Kinase 2 Inhibitors 43
Special Issue: “G Protein-Coupled Receptor and Their Kinases in Cell Biology and Disease 2.0” 39
Chronic β1-adrenergic blockade enhances myocardial β3-adrenergic coupling with nitric oxide-cGMP signaling in a canine model of chronic volume overload: New insight into mechanisms of cardiac benefit with selective β1-blocker therapy 39
G Protein-Coupled Receptor and Their Kinases in Cell Biology and Disease. 38
Identification and characterization of amlexanox as a G protein-coupled receptor kinase 5 inhibitor 38
Sex/Gender- and Age-Related Differences in β-Adrenergic Receptor Signaling in Cardiovascular Diseases 34
Investigating the association between the triglyceride-glucose index and peripheral artery disease: a systematic review and meta-analysis. 34
GRK2 compromises cardiomyocyte mitochondrial function by diminishing fatty acid-mediated oxygen consumption and increasing superoxide levels 33
Targeting GRK5 for treating chronic degenerative diseases 33
Beta-3 adrenergic receptor overexpression reverses aortic stenosis–induced heart failure and restores balanced mitochondrial dynamics 33
Polyunsaturated fatty acid status and markers of oxidative stress and inflammation across the lifespan: A cross-sectional study in a cohort with long-lived individuals 30
Exploring the role of β2- and β3-adrenergic receptors in cystic fibrosis. 28
null 14
null 11
Totale 6.998
Categoria #
all - tutte 23.648
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.648


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202152 0 0 0 0 0 12 6 5 15 2 0 12
2021/2022492 2 0 9 151 2 8 5 11 44 35 83 142
2022/2023557 58 35 21 21 52 58 5 58 117 89 24 19
2023/2024522 19 71 94 35 27 41 57 42 3 13 73 47
2024/20252.285 117 102 5 42 74 129 258 144 167 212 855 180
2025/20262.719 477 422 494 395 752 179 0 0 0 0 0 0
Totale 6.998